Evidence map›Paper›PMID 28944924›Full record

ArticleMolecular medicine reports2017

Cyclic helix B peptide protects HK‑2 cells from oxidative stress by inhibiting ER stress and activating Nrf2 signalling and autophagy.

Long Li, Miao Lin, Lexi Zhang, Shang Huang, Chao Hu, Long Zheng, Liping Li, Chao Zhang, Cheng Yang, Yaqiu Long and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Long LiDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Miao LinDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Lexi ZhangDepartment of Urology, Anhui Provincial Hospital, Hefei, Anhui 230001, P.R. China.
Shang HuangDepartment of Urology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China.
Chao HuDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Long ZhengDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Liping LiDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Chao ZhangDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Cheng YangDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Yaqiu LongCAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Ruiming RongDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
Tongyu ZhuDepartment of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China.
The First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CNZhongshan Hospital · CNAnhui Provincial Hospital · CNChinese Academy of Sciences · CNGuangdong General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal ischemia‑reperfusion injury (IRI) is present in numerous diseases and is observed following certain treatments, including renal transplantation. Preventing tubular epithelial cells (TECs) from undergoing apoptosis is vital for treatment of renal IRI. Cyclic helix B peptide (CHBP) is a novel agent that has a protective effect on renal IRI in vivo. In the present study, the effect and underlying mechanism of CHBP on TECs was investigated. The HK‑2 human renal proximal tubular epithelial cell line was treated with 500 µmol/l H2O2 for 4 h prior to determining the effect of CHBP pretreatment for 1 h on cell viability, caspase 3 activity and expression levels, expression levels of oxidative stress markers, endoplasmic reticulum (ER) stress markers, NF‑E2‑related factor 2 (Nrf2), heme oxygenase‑1 (HO‑1) and autophagy markers. This was investigated using a Cell Counting kit 8, a terminal deoxynucleotidyl transferase‑mediated dUTP nick‑end labelling assay, western blotting, reverse transcription‑quantitative polymerase chain reaction and immunocytochemistry. Results revealed that pretreatment with CHBP enhanced HK‑2 cell viability, the glutathione/glutathione disulphide ratio, activation of Nrf2 and mRNA expression levels of HO‑1 and the expression levels of beclin‑1 and light chain 3 A/B‑II/I. Conversely, CHBP pretreatment reduced the expression levels of reactive oxygen species, the activity and protein expression levels of capase‑3, the mRNA and protein expression levels of C/EBP homologous protein and binding immunoglobulin protein, and the expression levels of phosphorylated (p)‑mechanistic target of rapamycin (mTOR) Ser2448 and p62 during oxidative stress. However, the expression of p‑mTOR Ser2481 was enhanced after CHBP pretreatment. CHBP pretreatment reduced the expression levels of reactive oxygen species, the activity and protein expression levels of capase‑3, the mRNA and protein expression levels of C/EBP homologous protein and binding immunoglobulin protein, and the expression levels of phosphorylated (p)‑mechanistic target of rapamycin (mTOR) Ser2481, p62 and p‑mTOR Ser 2448 during oxidative stress. In conclusion, CHBP pretreatment protected HK‑2 cells from H2O2‑induced injury, inhibited ER stress and pro‑apoptotic pathways, and activated the Nrf2 signalling pathway and autophagy. These results provide a potential mechanism of how CHBP protects against renal IRI.

Indexed as

ApoptosisAutophagyBiomarkersCell SurvivalEndoplasmic Reticulum StressEpithelial CellsHumansHydrogen PeroxideKidney Tubules, ProximalNF-E2-Related Factor 2Oxidative StressPeptides, CyclicReactive Oxygen SpeciesReperfusion InjurySignal TransductionBiomarkersHydrogen PeroxideNF-E2-Related Factor 2Peptides, CyclicReactive Oxygen Species

Identifiers

PMID28944924
PMCPMC5779891
OpenAlexW2757014160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.